R&D Systems™ Recombinant Human TGF-beta 1 (Human Cell-expressed) Protein

Description

Extensive quality control produces industry leading bioactivity and lot-to-lot consistency that instills confidence in results and ensures reproducibility. Applications: Bioactivity

The Recombinant Human TGF-beta 1 (Human Cell-expressed) Protein is derived from HEK293. The Recombinant Human TGF-beta 1 (Human Cell-expressed) Protein has been validated for the following applications: Bioactivity.

Specifications

• Accession Number: P01137
• For Use With (Application): Bioactivity
• Gene ID (Entrez): 7040
• Molecular Weight (g/mol): 12.8 kDa (monomer)
• Quantity: 1000 μg
• Source: Human embryonic kidney cell,HEK293-derived human TGF-beta 1 protein Ala279-Ser390
• Storage Requirements: Use a manual defrost freezer and avoid repeated freeze-thaw cycles. 12 months from date of receipt, -20 to -70 °C as supplied. 1 month, 2 to 8 °C under sterile conditions after reconstitution. 3 months, -20 to -70 °C under sterile conditions after reconstitution.
• Regulatory Status: RUO
• Endotoxin Concentration: <0.01 EU per 1 μg of the protein by the LAL method.
• Gene Alias: CEDLAP, DPD1, latency-associated peptide, TGF beta1, TGFB, TGFB1, TGFbeta, TGFbeta 1, TGF-beta 1 protein, TGF-beta-1, transforming growth factor beta-1, transforming growth factor, beta 1
• Gene Symbol: TGFB1
• Specific Reactivity: TGF-beta 1
• Conjugate: Unconjugated
• Species: Human
• Recombinant: Recombinant
• Reconstitution: Reconstitute at 100 μg/mL in sterile 4 mM HCl containing at least 0.1% human or bovine serum albumin.
• Buffer: Lyophilized from a 0.2 μm filtered solution in Acetonitrile and TFA with BSA as a carrier protein. *1 mg pack size (01M) is supplied as a 0.2 μm filtered solution in Acetonitrile and TFA with BSA as a carrier protein.
• Purity or Quality Grade: >95%, by SDS-PAGE under reducing conditions and visualized by silver stain.